Kevin Kalinsky, MD (IMAGE)
Caption
Kevin Kalinsky, MD, is the study lead for the RxPONDER breast cancer clinical trial designed and managed by SWOG Cancer Research Network and funded by the National Cancer Institute.
Credit
Emory University
Usage Restrictions
Please credit Emory
License
Licensed content